Uraemic sera stimulate lipolysis in human adipocytes: Role of perilipin

Nephrology Dialysis Transplantation

Volumn 26, Issue 8, 2011, Pages 2485-2491

  Axelsson, Jonas ^a   Åström, Gaby ^b   Sjölin, Eva ^b   Qureshi, Abdul Rashid ^a   Lorente Cebrián, Silvia ^b   Stenvinkel, Peter ^a   Rydén, Mikael ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

adipocytes; chronic kidney disease; human; lipolysis; perilipin

Indexed keywords

ADIPOCYTOKINE; GLYCEROL; MESSENGER RNA; PERILIPIN; RNA; TRIACYLGLYCEROL LIPASE;

ADIPOCYTE; ADULT; AGE; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENDER; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; LIPOLYSIS; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ISOLATION; UREMIA; X RAY ABSORPTION SPECTROSCOPY;

ABSORPTIOMETRY, PHOTON; ADIPOCYTES; ADULT; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; GLYCEROL; HUMANS; INSULIN RESISTANCE; LIPOLYSIS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UREMIA;

EID: 79961081121     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq755     Document Type: Article

References (34)

1. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305
2. Axelsson J, Bergsten A, Qureshi AR et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006;69:596-604 (Pubitemid 43164455)
3. DeFronzo RA, Alvestrand A, Smith D et al. Insulin resistance in uremia. J Clin Invest 1981;67:563-568 (Pubitemid 11141740)
4. Miyamoto T, Qureshi AR, Yamamoto T et al. Postprandial metabolic response to a fat-and carbohydrate-rich meal in patients with chronic kidney disease. Nephrol Dial Transplant 2011;26:2231-2237
5. Muntner P, He J, Astor BC et al. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol 2005;16:529-538 (Pubitemid 41725151)
6. Shinohara K, Shoji T, Emoto M et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002;13:1894-1900 (Pubitemid 34700615)
7. Arner P. The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 2003;14:137-145 (Pubitemid 36733912)
8. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-867 (Pubitemid 46024993)
9. Axelsson J, Stenvinkel P. Role of fat mass and adipokines in chronic kidney disease. Curr Opin Nephrol Hypertens 2008;17:25-31 (Pubitemid 350295193)
10. Kalantar-Zadeh K, Abbott KC, Salahudeen AK et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;81:543-554
11. Axelsson J, Rashid Qureshi A, Suliman ME et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004;80:1222-1229 (Pubitemid 41350682)
12. Postorino M, Marino C, Tripepi G, Zoccali C. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009;53:1265-1272
13. Granneman JG, Moore HP, Granneman RL et al. Analysis of lipolytic protein trafficking and interactions in adipocytes. J Biol Chem 2007;282:5726-5735 (Pubitemid 47093761)
14. Tansey JT, Sztalryd C, Gruia-Gray J et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 2001;98:6494-6499 (Pubitemid 32488265)
15. Mottagui-Tabar S, Ryden M, Lofgren P et al. Evidence for an important role of perilipin in the regulation of human adipocyte lipolysis. Diabetologia 2003;46:789-797 (Pubitemid 36831407)
16. Ryden M, Arvidsson E, Blomqvist L et al. Targets for TNF-alphainduced lipolysis in human adipocytes. Biochem Biophys Res Commun 2004;318:168-175 (Pubitemid 38526261)
17. Agustsson T, Ryden M, Hoffstedt J et al. Mechanism of increased lipolysis in cancer cachexia. Cancer Res 2007;67:5531-5537 (Pubitemid 46997295)
18. Stenvinkel P, Heimbürger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911 (Pubitemid 29197978)
19. Hellmer J, Marcus C, Sonnenfeld T, Arner P. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab 1992;75:15-20
20. Pettersson AT, Laurencikiene J, Mejhert N et al. A possible inflammatory role of twist1 in human white adipocytes. Diabetes 2010;59:564-571
21. Mauriege P, Despres JP, Moorjani S et al. Abdominal and femoral adipose tissue lipolysis and cardiovascular disease risk factors in men. Eur J Clin Invest 1993;23:729-740 (Pubitemid 23349140)
22. Mittendorfer B, Patterson BW, Klein S. Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am J Clin Nutr 2003;77:573-579 (Pubitemid 36258564)
23. Abdul-Ghani MA, Muller FL, Liu Y et al. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. Am J Physiol Endocrinol Metab 2008;295:E678-E685
24. Ritz E, Wanner C. Lipid changes and statins in chronic renal insufficiency. J Am Soc Nephrol 2006;17(12 Suppl 3):S226-S230 (Pubitemid 44865253)
25. Ryden M, Arner P. Fat loss in cachexia-is there a role for adipocyte lipolysis? Clin Nutr 2007;26:1-6 (Pubitemid 46179125)
26. Kaye JP, Moorhead JF, Wills MR. Plasma lipids in patients with chronic renal failure. Clin Chim Acta 1973;44:301-305
27. Ryden M, Arner P. Tumour necrosis factor-alpha in human adipose tissue-from signalling mechanisms to clinical implications. J Intern Med 2007;262:431-438 (Pubitemid 47404374)
28. Laurencikiene J, van Harmelen V, Arvidsson Nordstrom E et al. NF-kappa B is important for TNF-alpha-induced lipolysis in human adipocytes. J Lipid Res 2007;48:1069-1077 (Pubitemid 46708674)
29. Zhou QG, Zhou M, Hou FF, Peng X. Asymmetrical dimethylarginine triggers lipolysis and inflammatory response via induction of endoplasmic reticulum stress in cultured adipocytes. Am J Physiol Endocrinol Metab 2009;296:E869-E878
30. Yilmaz MI, Sonmez A, Saglam M et al. ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction. J Am Soc Nephrol 2008;19:388-395 (Pubitemid 351240660)
31. Fricke K, Schulz A, John H et al. Isolation and characterization of a novel proopiomelanocortin-derived peptide from hemofiltrate of chronic renal failure patients. Endocrinology 2005;146:2060-2068 (Pubitemid 40396917)
32. Lafontan M, Moro C, Sengenes C et al. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans. Arterioscler Thromb Vasc Biol 2005;25:2032-2042 (Pubitemid 41416298)
33. Horl WH. Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy. J Investig Med 2005;53:366-370 (Pubitemid 41814250)
34. Arner P. Techniques for the measurement of white adipose tissue metabolism: a practical guide. Int J Obes Relat Metab Disord 1995;19:435-442